This article was prepared using automated systems that process publicly available information. It may contain inaccuracies or omissions and is provided for informational purposes only. Nothing herein constitutes financial, investment, legal, or tax advice.
Wall Street banks and private credit lenders are assembling €3.6 billion in debt financing to support GTCR’s acquisition of generic drugmaker Zentiva. The jumbo financing package involves major financial institutions including Goldman Sachs and JPMorgan. This deal represents one of the significant private equity transactions in the pharmaceutical sector this year.
- Goldman Sachs, JPMorgan, Morgan Stanley and Barclays lead €3.6B debt package
- Financing supports GTCR's $4.8B acquisition of generic drugmaker Zentiva
- Combination of Wall Street banks and private credit lenders in jumbo financing
📎 Related coverage from: bloomberg.com